News & Events

‘This is a solvable problem’: New Massachusetts studies, including one conducted in collaboration with the CCTR, aim to unlock the mysteries of chronic Lyme disease. A distinct ‘antibody signature’ could herald a new test to pinpoint who will recover. 

The new device, which can be incorporated into a bra, could allow more frequent monitoring of patients at high risk for breast cancer. The device's ultrasound technology was developed and tested in collaboration with the CCTR.

Join MeHI at the MassTech Collaborative (@MassEHealth) on June 28th at The Engine in Cambridge, MA for the Final Pitch Event for their Healthy Aging Sandbox Challenge.

Come join us for fun interactive activities (think yo-yo, think ping-pong) in the CCTR’s HealthLab and Motion Capture Suite.

Leuko is developing the world’s first portable, non-invasive white blood cell monitoring device to screen for severe neutropenia.

MIT researchers report early-stage clinical study results of tests with noninvasive 40-hertz light and sound treatment. The CCTR phlebotomy services are being utilized to support this study.

A collaboration between MIT’s Institute of Medical Engineering and Science (IMES) and the Sekisui House of Japan to research in-home wellness monitoring.